Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Bicalutamide EP Impurity F

Bicalutamide EP Impurity F is listed in the pharmaceutical impurity collection. Its represented structure has formula C18H14F4N2O3S and a calculated molecular weight of 414.38 g/mol.

2D chemical structure

H O S O F O N H N F F F ( S ) ( S )

Chemical identity

Catalog name
Bicalutamide EP Impurity F
Common name
Bicalutamide EP Impurity F
Chemical name
(2S)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(R)-(4-fluorophenyl)sulfinyl]-2-hydroxy-2-methylpropanamide
CAS
Not available
SMILES
C[C@@](O)(C[S@@](=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1
InChI
InChI=1S/C18H14F4N2O3S/c1-17(26,10-28(27)14-6-3-12(19)4-7-14)16(25)24-13-5-2-11(9-23)15(8-13)18(20,21)22/h2-8,26H,10H2,1H3,(H,24,25)/t17-,28-/m1/s1
InChIKey
MHWPKBKCPXTKJS-JYRCXFKTSA-N
Associated API
Bicalutamide

Record ID: A742cf20b12d7

Computed properties

C18H14F4N2O3S Molecular formula
414.38 g/molMolecular weight
414.0661 DaMonoisotopic exact mass
90.19 ŲTopological polar surface area
3.2135 Calculated LogP (Wildman–Crippen)
93.0879 cm³/molMolar refractivity (Wildman–Crippen)
4 countHydrogen-bond acceptors
2 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C F H N O S 0 4 8 12 16 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight414.3872.41
Calculated LogP (Wildman–Crippen)3.213565.77
Topological polar surface area90.1965.56
Hydrogen-bond acceptors450.68
Hydrogen-bond donors264.87
Rotatable bonds (strict)560.59

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC18H14F4N2O3Sdimensionless
Molecular weight414.38g/mol
Monoisotopic exact mass414.0661Da
Topological polar surface area90.19Ų
Calculated LogP (Wildman–Crippen)3.2135dimensionless
Molar refractivity (Wildman–Crippen)93.0879cm³/mol
Hydrogen-bond acceptors4count
Hydrogen-bond donors2count
Rotatable bonds (strict)5count
Heavy atoms28count
Heteroatoms10count
Rings2count
Aromatic rings2count
Aliphatic rings0count
Saturated rings0count
Aromatic heterocycles0count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles2count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.2222fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters2count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area159.6127Ų
Valence electrons148count
Radical electrons0count
Bertz complexity950.7836index
Balaban J2.1767index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Bicalutamide EP Impurity F

Qualification and safety assessment of Bicalutamide EP Impurity F

Explore toxicological qualification of Bicalutamide EP Impurity F and ICH M7 mutagenic impurity assessment of Bicalutamide EP Impurity F for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Bicalutamide EP Impurity F and acceptable intake and limit justification for Bicalutamide EP Impurity F. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Bicalutamide EP Impurity F

Explore Altox services and software through the Altox Pharma-Hub.